
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Prognostic value of the co-stimulatory molecule OX40 expression in Extranodal Natural Killer/T-cell Lymphoma - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15251C338AEEF613051C3300681E779F.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="annmed">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12377112/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Annals of Medicine">
<meta name="citation_title" content="Prognostic value of the co-stimulatory molecule OX40 expression in Extranodal Natural Killer/T-cell Lymphoma">
<meta name="citation_author" content="Haiyan Zhang">
<meta name="citation_author_institution" content="Department of Hematology, The Affiliated Shuyang Hospital of Xuzhou Medical University, Suqian, China">
<meta name="citation_author" content="Yujie Li">
<meta name="citation_author_institution" content="Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Qing Zhang">
<meta name="citation_author_institution" content="Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Yubo Wang">
<meta name="citation_author_institution" content="Department of Pathology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Shuo Zhang">
<meta name="citation_author_institution" content="Department of Hematology, Linyi People’s Hospital, Linyi, China">
<meta name="citation_author" content="Xing Xing">
<meta name="citation_author_institution" content="Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China">
<meta name="citation_author" content="Ziyuan Shen">
<meta name="citation_author_institution" content="Clinical Research Institute, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Hui Liu">
<meta name="citation_author_institution" content="Department of Pathology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author" content="Wei Sang">
<meta name="citation_author_institution" content="Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China">
<meta name="citation_author_institution" content="Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China">
<meta name="citation_publication_date" content="2025 Aug 23">
<meta name="citation_volume" content="57">
<meta name="citation_issue" content="1">
<meta name="citation_firstpage" content="2550583">
<meta name="citation_doi" content="10.1080/07853890.2025.2550583">
<meta name="citation_pmid" content="40847620">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12377112/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12377112/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12377112/pdf/IANN_57_2550583.pdf">
<meta name="description" content="To explore the clinicopathological features and the prognostic values of the co-stimulatory molecules OX40 and the inducible T-cell co-stimulator (ICOS) in Extranodal Natural Killer/T-cell Lymphoma (ENKTL). 82 participants (median age 51 years, ...">
<meta name="og:title" content="Prognostic value of the co-stimulatory molecule OX40 expression in Extranodal Natural Killer/T-cell Lymphoma">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="To explore the clinicopathological features and the prognostic values of the co-stimulatory molecules OX40 and the inducible T-cell co-stimulator (ICOS) in Extranodal Natural Killer/T-cell Lymphoma (ENKTL). 82 participants (median age 51 years, ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12377112/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12377112">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1080/07853890.2025.2550583"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/IANN_57_2550583.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12377112%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12377112/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12377112/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12377112/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-annmed.gif" alt="Annals of Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Annals of Medicine" title="Link to Annals of Medicine" shape="default" href="https://www.tandfonline.com/toc/iann20/current" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Ann Med</button></div>. 2025 Aug 23;57(1):2550583. doi: <a href="https://doi.org/10.1080/07853890.2025.2550583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1080/07853890.2025.2550583</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Ann%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ann%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Ann%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Ann%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Prognostic value of the co-stimulatory molecule OX40 expression in Extranodal Natural Killer/T-cell Lymphoma</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Haiyan Zhang</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Haiyan Zhang</span></h3>
<div class="p">
<sup>a</sup>Department of Hematology, The Affiliated Shuyang Hospital of Xuzhou Medical University, Suqian, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Haiyan Zhang</span></a>
</div>
</div>
<sup>a</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Yujie Li</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Yujie Li</span></h3>
<div class="p">
<sup>b</sup>Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Li%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yujie Li</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Q%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Qing Zhang</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Qing Zhang</span></h3>
<div class="p">
<sup>b</sup>Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20Q%22%5BAuthor%5D" class="usa-link"><span class="name western">Qing Zhang</span></a>
</div>
</div>
<sup>b</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Yubo Wang</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Yubo Wang</span></h3>
<div class="p">
<sup>c</sup>Department of Pathology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Wang%20Y%22%5BAuthor%5D" class="usa-link"><span class="name western">Yubo Wang</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Shuo Zhang</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Shuo Zhang</span></h3>
<div class="p">
<sup>d</sup>Department of Hematology, Linyi People’s Hospital, Linyi, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zhang%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuo Zhang</span></a>
</div>
</div>
<sup>d</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xing%20X%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Xing Xing</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Xing Xing</span></h3>
<div class="p">
<sup>e</sup>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Xing%20X%22%5BAuthor%5D" class="usa-link"><span class="name western">Xing Xing</span></a>
</div>
</div>
<sup>e</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shen%20Z%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Ziyuan Shen</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Ziyuan Shen</span></h3>
<div class="p">
<sup>f</sup>Clinical Research Institute, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Shen%20Z%22%5BAuthor%5D" class="usa-link"><span class="name western">Ziyuan Shen</span></a>
</div>
</div>
<sup>f</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Hui Liu</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Hui Liu</span></h3>
<div class="p">
<sup>c</sup>Department of Pathology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Liu%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Hui Liu</span></a>
</div>
</div>
<sup>c</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sang%20W%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Wei Sang</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Wei Sang</span></h3>
<div class="p">
<sup>b</sup>Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div class="p">
<sup>g</sup>Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sang%20W%22%5BAuthor%5D" class="usa-link"><span class="name western">Wei Sang</span></a>
</div>
</div>
<sup>b,</sup><sup>g,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="AF0001">
<sup>a</sup>Department of Hematology, The Affiliated Shuyang Hospital of Xuzhou Medical University, Suqian, China</div>
<div id="AF0002">
<sup>b</sup>Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div id="AF0003">
<sup>c</sup>Department of Pathology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div id="AF0004">
<sup>d</sup>Department of Hematology, Linyi People’s Hospital, Linyi, China</div>
<div id="AF0005">
<sup>e</sup>Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, Hefei, China</div>
<div id="AF0006">
<sup>f</sup>Clinical Research Institute, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China</div>
<div id="AF0007">
<sup>g</sup>Blood Diseases Institute, Xuzhou Medical University, Xuzhou, China</div>
<div class="author-notes p">
<div class="fn" id="AUFN1"><p>Supplemental data for this article can be accessed online at <a href="https://doi.org/10.1080/07853890.2025.2550583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://doi.org/10.1080/07853890.2025.2550583</a>.</p></div>
<div class="fn" id="AN0001">
<sup>✉</sup><p class="display-inline">CONTACT Wei Sang <span>xyfylbl515@xzhmu.edu.cn</span>
Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, 221006, China.</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Apr 24; Accepted 2025 Mar 13; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2025 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group</div>
<p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<a href="https://creativecommons.org/licenses/by-nc/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by-nc/4.0/</a>), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12377112  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40847620/" class="usa-link">40847620</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Objective</h3>
<p>To explore the clinicopathological features and the prognostic values of the co-stimulatory molecules OX40 and the inducible T-cell co-stimulator (ICOS) in Extranodal Natural Killer/T-cell Lymphoma (ENKTL).</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p>82 participants (median age 51 years, 26.8% female) were included in this study. OX40 and ICOS expression was detected using immunohistochemistry on paraffin‑embedded sections. The level of OX40 and ICOS expression was categorized into negative (0%, no staining) and positive groups. Kaplan-Meier analysis was used to estimate the probability of survival rates, and group comparisons were made using the Log-rank test.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p>Positive staining for OX40 and ICOS was observed in 64 (78.0%) and 48 (58.5%) cases, respectively. The main differences between OX40-positive and OX40-negative were in the Chinese Southwest Oncology Group and Asia Lymphoma Study Group ENKTL (CA) stage, Korean Prognostic Index (KPI), CD68, PD1, PDL1, and CD152. Patients exhibiting positive OX40 expression demonstrated a statistically significant improvement in survival compared to the negative group (<em>p</em> &lt; 0.001). However, no statistically significant survival difference was observed between ICOS-negative and ICOS-positive patients (<em>p</em> = 0.760). The expression of OX40 was a favorable prognostic indicator for ENKTL patients (<em>Hazard Ratio</em> = 0.049, 95% confidence interval: 0.009–0.285, <em>p</em> &lt; 0.001) in multivariable analysis.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p>Our findings reveal that positive OX40 expression serves as an independent prognostic marker for improved survival of ENKTL, suggesting its potential utility in stratifying patient risk and optimizing treatment strategies. Future research should focus on the therapeutic targeting of OX40 in ENKTL.</p></section><section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> Extranodal Natural killer/T-Cell Lymphoma, inducible T-cell co-stimulator, OX40, prognosis</p></section></section><section id="S0001"><h2 class="pmc_sec_title">Introduction</h2>
<p>Extranodal Natural Killer/T-cell Lymphoma (ENKTL) is an aggressive lymphoma predominantly found in East Asia and South America [<a href="#CIT0001" class="usa-link" aria-describedby="CIT0001">1</a>,<a href="#CIT0002" class="usa-link" aria-describedby="CIT0002">2</a>], and it is universally associated with Epstein-Barr virus (EBV) infection, which contributes to poor survival outcomes [<a href="#CIT0003" class="usa-link" aria-describedby="CIT0003">3</a>,<a href="#CIT0004" class="usa-link" aria-describedby="CIT0004">4</a>]. Non-anthracycline-based regimens have been widely used as the first-line treatment for ENKTL, providing significant therapeutic benefits [<a href="#CIT0005" class="usa-link" aria-describedby="CIT0005">5</a>]. Notably, L-asparaginase-based regimens have been shown to achieve complete remission rates of approximately 55% to 80% in patients with early stage ENKTL [<a href="#CIT0006" class="usa-link" aria-describedby="CIT0006">6</a>,<a href="#CIT0007" class="usa-link" aria-describedby="CIT0007">7</a>]. However, there remains a high incidence of resistance or relapse among patients in advanced stages, those at high risk, and those with high EBV loads. This situation highlights the importance of the tumor microenvironment, which significantly influences the progression of ENKTL through altered cytokine and chemokine expression, affecting immune dynamics. Within this immune microenvironment, the activation of T cells is crucial for anti-tumor immune responses, a process that relies on efficient co-stimulatory molecules and the regulation of immune checkpoints [<a href="#CIT0008" class="usa-link" aria-describedby="CIT0008">8</a>].</p>
<p>Immune checkpoints serve a crucial function in lymphoma, acting as key regulators in immune responses. These checkpoints, which encompass Programmed Death-1 (PD-1), Programmed Death-Ligand 1 (PD-L1), and Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), are vital mechanisms that modulate the immune system’s activity and response [<a href="#CIT0009" class="usa-link" aria-describedby="CIT0009">9–12</a>]. OX40 (also known as CD134) is a member of the tumor necrosis factor superfamily, playing a crucial role in promoting T-cell survival and regulating cytokine receptor signaling [<a href="#CIT0013" class="usa-link" aria-describedby="CIT0013">13</a>]. Inducible T-cell co-stimulator (also known as ICOS, CD278, AILIM, H4) is a costimulatory receptor for T-cell enhancement and a member of the B7/CD28 receptor superfamily [<a href="#CIT0014" class="usa-link" aria-describedby="CIT0014">14</a>]. Moreover, ICOS and OX40 are pivotal in the development and persistence of central memory T cells [<a href="#CIT0015" class="usa-link" aria-describedby="CIT0015">15</a>]. ICOS and OX40 not only enhance T cell activation, expansion, and survival but also contribute to the development of a robust and durable memory T cell response, essential for forming a long-term protective immunity pool [<a href="#CIT0016" class="usa-link" aria-describedby="CIT0016">16</a>]. In a retrospective study of 52 patients with Peripheral T-cell lymphoma, no significant survival differences were observed between individuals with positive versus negative OX40 expression [<a href="#CIT0017" class="usa-link" aria-describedby="CIT0017">17</a>]. Conversely, Lu et al. reported that high OX40 expression was associated with improved clinical outcomes in patients with diffuse large B-cell lymphoma (DLBCL) [<a href="#CIT0018" class="usa-link" aria-describedby="CIT0018">18</a>]. These findings suggest a complex and context-dependent role of co-stimulatory molecules in lymphoma pathogenesis and highlight the variability in their prognostic impact across different lymphoma subtypes. ENKTL is known for its aggressive behavior and unique immunological features compared to other lymphomas. However, the prognostic roles of OX40 and ICOS in ENKTL have not yet been explored. Therefore, this study aimed to evaluate the clinicopathological characteristics and the prognostic significance of OX40 and ICOS in ENKTL. By focusing on these co-stimulatory molecules, we aim to provide an understanding of their role in ENKTL, thereby contributing significantly to the development of targeted treatment strategies.</p></section><section id="S0002"><h2 class="pmc_sec_title">Material and methods</h2>
<section id="S0002-S2001"><h3 class="pmc_sec_title">Patients</h3>
<p>A total of 82 patients with pathologically confirmed ENKTL diagnosed at the Affiliated Hospital of Xuzhou Medical University from January 2011 to July 2020 were included. Exclusion criteria included patients with incomplete clinical records (e.g. the absence of essential immunohistochemistry data or missing baseline clinical characteristics) or a history of other malignancies. Among patients with evaluable treatment information, a variety of first-line therapeutic regimens were administered. Eleven patients received the DDGP regimen (dexamethasone, cisplatin, gemcitabine, and pegaspargase), six were treated with the SMILE regimen (dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide), and another six received gemcitabine plus L-asparaginase-based therapies. Four patients were treated with pegaspargase- or L-asparaginase-based regimens alone. Additionally, eight patients received CHOP or CHOP-like regimens, and fifteen patients underwent radiotherapy. Ethics approval was obtained from the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University (No. XYFY2022-KL363-01). All participants provided written informed consent. This study was conducted following the Declaration of Helsinki.</p></section><section id="S0002-S2002"><h3 class="pmc_sec_title">Immunohistochemistry</h3>
<p>Clinicopathological variables and outcomes were obtained from the Pathology Department. Formalin-fixed, 4-µm thick, paraffin-embedded biopsy samples were collected at baseline. Immunohistochemical staining for ICOS (clone <a href="https://www.ncbi.nlm.nih.gov/protein/EPR20560" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">EPR20560</a>), PD-1 (clone UMAB199, ready-to-use), and P53 (clone DO-7) was carried out using the EnVision immunohistochemistry kit, biotinylated secondary antibody working solution, and horseradish peroxidase (HRP) working solution. Ten fields were observed for ICOS and OX40 staining using <em>a</em> × 400 magnification microscope (×22 objective with ×10 eyepiece). Immunohistochemical staining for OX40 and ICOS was classified as negative when no staining was observed. Positive staining was defined as any detectable staining above background levels. The average percentage of positive tumor cells/stromal cells was calculated based on these observations. The expression of these biomarkers in each case was evaluated, correlating with clinicopathologic features.</p></section><section id="S0002-S2003"><h3 class="pmc_sec_title">Covariates</h3>
<p>Covariates were selected based on previous literature [<a href="#CIT0019" class="usa-link" aria-describedby="CIT0019">19–23</a>]: age, gender, Eastern Cooperative Oncology Group performance status (ECOG PS), the presence of B symptoms, serum lactate dehydrogenase (LDH, U/L), and Epstein-Barr encoding region (EBER) status. The disease stage was divided according to the Ann Arbor classification system and the Chinese Southwest Oncology Group and Asia Lymphoma Study Group ENKTL (CA) system [<a href="#CIT0024" class="usa-link" aria-describedby="CIT0024">24</a>]. The CA system is specifically designed for ENKTL and provides improved prognostic relevance by accounting for extranodal spread and anatomical patterns typical of this disease.</p>
<p>Prognostic stratification was performed using four established indices: the Korean Prognostic Index (KPI), International Prognostic Index (IPI), Nomogram-Revised Index (NRI), and Prognostic Index of Natural Killer lymphoma (PINK). The KPI evaluates stage, B symptoms, serum LDH levels, and regional lymph node involvement.</p>
<p>The IPI incorporates age, ECOG performance status, LDH, stage, and the number of extranodal sites. The NRI is a nomogram-based scoring system tailored for NK/T-cell lymphoma, integrating clinical and laboratory parameters. The PINK is specifically developed for ENKTL and includes age &gt;60, stage III/IV, non-nasal type, and distant lymph-node involvement. For each patient, the corresponding scores were calculated, and risk categories were assigned according to the original publications.</p></section><section id="S0002-S2004"><h3 class="pmc_sec_title">Follow-up</h3>
<p>The patient’s status was confirmed by consulting the patient’s inpatient and outpatient medical record systems, and the follow-up method was conducted by telephone calls or self-return to the hospital for re-examination. Overall survival (OS) was calculated as the duration between the time of diagnosis and the date of death or the last follow-up. All patients were followed up until May 2023.</p></section><section id="S0002-S2005"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p>Baseline characteristics were presented as mean (standard deviation, SD) and n (%). Chi-square test and Mann-Whitney <em>U</em> test were utilized for the comparison of different groups. OS was evaluated using the Kaplan-Meier method, and group comparisons were made with the Log-rank test. Univariable and multivariable analyses were performed with Cox proportional hazards regression models. A stepwise regression approach, alternating between forward selection and backward elimination, was applied. The results were presented as hazard ratios (<em>HR</em>s) and 95% confidence intervals (<em>CI</em>s). All risk factors with a <em>p</em> &lt; 0.05 in univariable analysis were included in the multivariable analysis. A Cox proportional hazards regression model with backward selection was used to identify risk factors.</p>
<p>All statistical analyses were performed by R software (version 4.2.2; <a href="http://www.%20Rproject.org" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://www. Rproject.org</a>). Statistical significance was set at a <em>P</em> value of &lt; 0.05 (two-tailed).</p></section></section><section id="S0003"><h2 class="pmc_sec_title">Results</h2>
<section id="S0003-S2001"><h3 class="pmc_sec_title">Baseline characteristics</h3>
<p>A total of 82 participants were included in this study. The baseline characteristics were presented in <a href="#t0001" class="usa-link">Table 1</a>. The median age was 51 years and 26.8% were female. The 5-y OS was 61.8% and the median follow-up time was 87.0 (95% <em>CI</em>: 77.5–96.4) months.</p>
<section class="tw xbox font-sm" id="t0001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Clinicopathological differences between OX40-positive and negative cases.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
</colgroup>
<thead><tr>
<th colspan="2" align="left" rowspan="1">Variables</th>
<th align="center" colspan="1" rowspan="1">Overall<br>(<em>n</em> = 82)</th>
<th align="center" colspan="1" rowspan="1">Negative<br>(<em>n</em> = 18)</th>
<th align="center" colspan="1" rowspan="1">Positive<br>(<em>n</em> = 64)</th>
<th align="center" colspan="1" rowspan="1">
<em>P</em>
</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1">Age (mean (SD))</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="center" colspan="1" rowspan="1">49.55 (18.07)</td>
<td align="center" colspan="1" rowspan="1">45.67 (15.33)</td>
<td align="center" colspan="1" rowspan="1">50.64 (18.73)</td>
<td align="center" colspan="1" rowspan="1">0.305</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gender (%)</td>
<td align="left" colspan="1" rowspan="1">Male</td>
<td align="center" colspan="1" rowspan="1">60 (73.2)</td>
<td align="center" colspan="1" rowspan="1">14 (77.8)</td>
<td align="center" colspan="1" rowspan="1">46 (71.9)</td>
<td align="center" colspan="1" rowspan="1">0.843</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Female</td>
<td align="center" colspan="1" rowspan="1">22 (26.8)</td>
<td align="center" colspan="1" rowspan="1">4 (22.2)</td>
<td align="center" colspan="1" rowspan="1">18 (28.1)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Ann Arbor Stage (%)</td>
<td align="left" colspan="1" rowspan="1">I/II</td>
<td align="center" colspan="1" rowspan="1">73 (89.0)</td>
<td align="center" colspan="1" rowspan="1">16 (88.9)</td>
<td align="center" colspan="1" rowspan="1">57 (89.1)</td>
<td align="center" colspan="1" rowspan="1">&gt;0.999</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">III/IV</td>
<td align="center" colspan="1" rowspan="1">9 (11.0)</td>
<td align="center" colspan="1" rowspan="1">2 (11.1)</td>
<td align="center" colspan="1" rowspan="1">7 (10.9)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CA (%)</td>
<td align="left" colspan="1" rowspan="1">I/II</td>
<td align="center" colspan="1" rowspan="1">60 (73.2)</td>
<td align="center" colspan="1" rowspan="1">9 (50.0)</td>
<td align="center" colspan="1" rowspan="1">51 (79.7)</td>
<td align="center" colspan="1" rowspan="1">
<strong>0.027</strong>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">III/IV</td>
<td align="center" colspan="1" rowspan="1">22 (26.8)</td>
<td align="center" colspan="1" rowspan="1">9 (50.0)</td>
<td align="center" colspan="1" rowspan="1">13 (20.3)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ECOG PS (%)</td>
<td align="left" colspan="1" rowspan="1">&lt;2</td>
<td align="center" colspan="1" rowspan="1">59 (72.0)</td>
<td align="center" colspan="1" rowspan="1">14 (77.8)</td>
<td align="center" colspan="1" rowspan="1">45 (70.3)</td>
<td align="center" colspan="1" rowspan="1">0.744</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">≥2</td>
<td align="center" colspan="1" rowspan="1">23 (28.0)</td>
<td align="center" colspan="1" rowspan="1">4 (22.2)</td>
<td align="center" colspan="1" rowspan="1">19 (29.7)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">B symptom (%)</td>
<td align="left" colspan="1" rowspan="1">Absence</td>
<td align="center" colspan="1" rowspan="1">48 (58.5)</td>
<td align="center" colspan="1" rowspan="1">8 (44.4)</td>
<td align="center" colspan="1" rowspan="1">40 (62.5)</td>
<td align="center" colspan="1" rowspan="1">0.270</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Presence</td>
<td align="center" colspan="1" rowspan="1">34 (41.5)</td>
<td align="center" colspan="1" rowspan="1">10 (55.6)</td>
<td align="center" colspan="1" rowspan="1">24 (37.5)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">KPI (%)</td>
<td align="left" colspan="1" rowspan="1">LR</td>
<td align="center" colspan="1" rowspan="1">25 (30.5)</td>
<td align="center" colspan="1" rowspan="1">3 (16.7)</td>
<td align="center" colspan="1" rowspan="1">22 (34.4)</td>
<td align="center" colspan="1" rowspan="1">0.039</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">LIR</td>
<td align="center" colspan="1" rowspan="1">30 (36.6)</td>
<td align="center" colspan="1" rowspan="1">4 (22.2)</td>
<td align="center" colspan="1" rowspan="1">26 (40.6)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">HIR</td>
<td align="center" colspan="1" rowspan="1">19 (23.2)</td>
<td align="center" colspan="1" rowspan="1">8 (44.4)</td>
<td align="center" colspan="1" rowspan="1">11 (17.2)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">HR</td>
<td align="center" colspan="1" rowspan="1">8 (9.8)</td>
<td align="center" colspan="1" rowspan="1">3 (16.7)</td>
<td align="center" colspan="1" rowspan="1">5 (7.8)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NRI (%)</td>
<td align="left" colspan="1" rowspan="1">ILR</td>
<td align="center" colspan="1" rowspan="1">16 (19.51)</td>
<td align="center" colspan="1" rowspan="1">1 (5.56)</td>
<td align="center" colspan="1" rowspan="1">15 (24.59)</td>
<td align="center" colspan="1" rowspan="1">0.154</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">IHR</td>
<td align="center" colspan="1" rowspan="1">45 (54.88)</td>
<td align="center" colspan="1" rowspan="1">14 (77.78)</td>
<td align="center" colspan="1" rowspan="1">31 (48.44)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">HR</td>
<td align="center" colspan="1" rowspan="1">13 (15.85)</td>
<td align="center" colspan="1" rowspan="1">2 (11.11)</td>
<td align="center" colspan="1" rowspan="1">11 (17.19)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Very HR</td>
<td align="center" colspan="1" rowspan="1">8 (9.76)</td>
<td align="center" colspan="1" rowspan="1">1 (5.56)</td>
<td align="center" colspan="1" rowspan="1">7 (10.94)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">PINK (%)</td>
<td align="left" colspan="1" rowspan="1">LR</td>
<td align="center" colspan="1" rowspan="1">29 (35.4)</td>
<td align="center" colspan="1" rowspan="1">6 (33.3)</td>
<td align="center" colspan="1" rowspan="1">23 (35.9)</td>
<td align="center" colspan="1" rowspan="1">0.307</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">IR</td>
<td align="center" colspan="1" rowspan="1">32 (39.0)</td>
<td align="center" colspan="1" rowspan="1">5 (27.8)</td>
<td align="center" colspan="1" rowspan="1">27 (42.2)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">HR</td>
<td align="center" colspan="1" rowspan="1">21 (25.6)</td>
<td align="center" colspan="1" rowspan="1">7 (38.9)</td>
<td align="center" colspan="1" rowspan="1">14 (21.9)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">IPI (%)</td>
<td align="left" colspan="1" rowspan="1">LR</td>
<td align="center" colspan="1" rowspan="1">54 (65.9)</td>
<td align="center" colspan="1" rowspan="1">12 (66.7)</td>
<td align="center" colspan="1" rowspan="1">42 (65.6)</td>
<td align="center" colspan="1" rowspan="1">0.856</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">LIR</td>
<td align="center" colspan="1" rowspan="1">18 (22.0)</td>
<td align="center" colspan="1" rowspan="1">3 (16.7)</td>
<td align="center" colspan="1" rowspan="1">15 (23.4)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">HIR</td>
<td align="center" colspan="1" rowspan="1">6 (7.3)</td>
<td align="center" colspan="1" rowspan="1">2 (11.1)</td>
<td align="center" colspan="1" rowspan="1">4 (6.2)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">HR</td>
<td align="center" colspan="1" rowspan="1">4 (4.9)</td>
<td align="center" colspan="1" rowspan="1">1 (5.6)</td>
<td align="center" colspan="1" rowspan="1">3 (4.7)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">&gt;240</td>
<td align="center" colspan="1" rowspan="1">34 (41.5)</td>
<td align="center" colspan="1" rowspan="1">11 (61.1)</td>
<td align="center" colspan="1" rowspan="1">23 (35.9)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">EBER</td>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="center" colspan="1" rowspan="1">12 (14.63)</td>
<td align="center" colspan="1" rowspan="1">3 (16.67)</td>
<td align="center" colspan="1" rowspan="1">9 (14.06)</td>
<td align="center" colspan="1" rowspan="1">0.782</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="center" colspan="1" rowspan="1">70 (85.37)</td>
<td align="center" colspan="1" rowspan="1">15 (83.33)</td>
<td align="center" colspan="1" rowspan="1">55 (55.94)</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="TF1"><p>Note: CA: Chinese Southwest Oncology Group and Asia Lymphoma Study Group staging system; ECOG PS: Eastern Cooperative Oncology Group performance status; KPI: Korean Prognostic Index; NRI: the nomogram-revised risk index; PINK: Prognostic index of natural killer lymphoma; IPI: International Prognostic Index; LR: low risk; ILR: intermediate low risk; IHR: high risk; HR: intermediate high risk; LDH: serum lactate dehydrogenase.</p></div></div></section></section><section id="S0003-S2002"><h3 class="pmc_sec_title">Immunohistochemical characteristics of OX40 and ICOS</h3>
<p>Positive staining for OX40 and ICOS was primarily localized in the membrane of tumor cells (<a href="#F0001" class="usa-link">Figure 1</a>). Among these samples, 64 (78.0%) showed positive staining for OX40, and 48 (58.5%) showed positive staining for ICOS. Notably, 45 samples were found to be double positive.</p>
<figure class="fig xbox font-sm" id="F0001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12377112_IANN_A_2550583_F0001_C.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f8/12377112/40d1242725b2/IANN_A_2550583_F0001_C.jpg" loading="lazy" height="1085" width="750" alt="Figure 1."></a></p>
<div class="p text-right font-secondary"><a href="figure/F0001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Representative histological (HE) and immunohistochemical staining of OX40 and ICOS in ENKTL. A: HE of OX40-positive; B: HE of OX40-negative; C: HE of ICOS-positive; D: HE of ICOS-negative; E: immunohistochemical staining of OX40-positive; F: immunohistochemical staining of OX40-negative; G: immunohistochemical staining of ICOS-positive; H: immunohistochemical staining of ICOS-negative; (original magnification, ×400 for all panels).</p></figcaption></figure></section><section id="S0003-S2003"><h3 class="pmc_sec_title">Clinicopathological characteristics of OX40 and ICOS</h3>
<p>OX40-positive and OX40-negative groups differed mainly in CA stage (<a href="#t0001" class="usa-link">Table 1</a>). ICOS-negative and ICOS-positive groups only differed in CD152 background cells (<a href="https://doi.org/10.1080/07853890.2025.2550583" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Supplementary Table 1</a>).</p></section><section id="S0003-S2004"><h3 class="pmc_sec_title">Survival analysis of OX40 and ICOS</h3>
<p>Patients exhibiting positive OX40 expression demonstrated a statistically significant improvement in OS compared to the negative group (<em>p</em> &lt; 0.001, <a href="#F0002" class="usa-link">Figure 2(A)</a>). In contrast, no statistically significant survival difference was observed between ICOS-negative and ICOS-positive patients (<em>p</em> = 0.760, <a href="#F0002" class="usa-link">Figure 2B</a>). Additionally, when analyzing subgroups with mixed expressions, the OX40+/ICOS- subgroup, comprising 19 patients, showed better survival outcomes compared to the three patients in the ICOS+/OX40- subgroup. Upon combining the data for OX40 and ICOS expression, a notable enhancement in survival was observed in patients from the dual-positive group, when compared with both the dual-negative group (<em>p</em> = 0.004).</p>
<figure class="fig xbox font-sm" id="F0002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12377112_IANN_A_2550583_F0002_C.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f8/12377112/6345bd60ac7d/IANN_A_2550583_F0002_C.jpg" loading="lazy" height="377" width="750" alt="Figure 2."></a></p>
<div class="p text-right font-secondary"><a href="figure/F0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan-Meier Survival curves of ENKTL patients. (A) OX40 status; (B) ICOS status.</p></figcaption></figure><p><a href="#t0002" class="usa-link">Table 2</a> showed the results of the univariable analysis. After multiple iterations in the multivariable analysis, we found that advanced CA stage was an adverse prognostic factor (<em>HR</em> = 2.258, 95% <em>CI</em>: 1.004–5.077, <em>p</em> = 0.049). Conversely, the expression of OX40 was a favorable prognostic indicator for ENKTL patients (<em>HR</em> = 0.049, 95% <em>CI</em>: 0.009–0.285, <em>p</em> &lt; 0.001).</p>
<section class="tw xbox font-sm" id="t0002"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Univariable analysis of prognostic factors for OS in ENKTL patients.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<colgroup span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
<col width="80pt" span="1">
</colgroup>
<thead><tr>
<th colspan="2" align="left" rowspan="1">Variables</th>
<th align="center" colspan="1" rowspan="1">
<em>HR</em>
</th>
<th align="center" colspan="1" rowspan="1">95% <em>CI</em>
</th>
<th align="center" colspan="1" rowspan="1">
<em>P</em>
</th>
</tr></thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1">Ann Arbor Stage</td>
<td align="left" colspan="1" rowspan="1">I/II</td>
<td align="center" colspan="1" rowspan="1">1</td>
<td align="center" colspan="1" rowspan="1">
<em>Ref</em>
</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">III/IV</td>
<td align="center" colspan="1" rowspan="1">2.672</td>
<td align="center" colspan="1" rowspan="1">1.093–6.531</td>
<td align="center" colspan="1" rowspan="1">0.031</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CA Stage</td>
<td align="left" colspan="1" rowspan="1">I/II</td>
<td align="center" colspan="1" rowspan="1">1</td>
<td align="center" colspan="1" rowspan="1">
<em>Ref</em>
</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">III/IV</td>
<td align="center" colspan="1" rowspan="1">3.276</td>
<td align="center" colspan="1" rowspan="1">1.610–6.664</td>
<td align="center" colspan="1" rowspan="1">0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OX40</td>
<td align="left" colspan="1" rowspan="1">Negative</td>
<td align="center" colspan="1" rowspan="1">1</td>
<td align="center" colspan="1" rowspan="1">
<em>Ref</em>
</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Positive</td>
<td align="center" colspan="1" rowspan="1">0.236</td>
<td align="center" colspan="1" rowspan="1">0.115–0.484</td>
<td align="center" colspan="1" rowspan="1">&lt;0.001</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">OX40/ICOS</td>
<td align="left" colspan="1" rowspan="1">Dual negative</td>
<td align="center" colspan="1" rowspan="1">1</td>
<td align="center" colspan="1" rowspan="1">
<em>Ref</em>
</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Others</td>
<td align="center" colspan="1" rowspan="1">0.262</td>
<td align="center" colspan="1" rowspan="1">0.095–0.724</td>
<td align="center" colspan="1" rowspan="1">0.010</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1">Dual positive</td>
<td align="center" colspan="1" rowspan="1">0.320</td>
<td align="center" colspan="1" rowspan="1">0.143–0.716</td>
<td align="center" colspan="1" rowspan="1">0.006</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/t0002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="TF2"><p>Note: CA: Chinese Southwest Oncology Group and Asia Lymphoma Study Group staging system; ICOS: inducible T-cell co-stimulator.</p></div></div></section></section><section id="S0003-S2005"><h3 class="pmc_sec_title">Subgroup analysis of OX40 and ICOS expression with clinicopathological indexes</h3>
<p>To explore the prognostic values of OX40 and ICOS expression in different clinicopathological indexes, a subgroup analysis was conducted. These findings revealed a significant correlation between CD152 and ICOS (<em>r</em> = 0.368, <em>p</em> = 0.012). OX40 expression could stratify the survival of patients in ECOG (&lt;2), Ann Arbor stage, CA stage, PINK (IR/HR), CD38-positive, PD1, CD30, CD152-positive, P53-positive, and CD68-positive groups (<a href="#F0003" class="usa-link">Figure 3</a>).</p>
<figure class="fig xbox font-sm" id="F0003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12377112_IANN_A_2550583_F0003_C.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87f8/12377112/43c562fd70e1/IANN_A_2550583_F0003_C.jpg" loading="lazy" height="522" width="750" alt="Figure 3."></a></p>
<div class="p text-right font-secondary"><a href="figure/F0003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Kaplan-Meier Survival curves of ENKTL patients. OX40 expression in (A) ECOG (&lt;2) group; (B) Ann arbor stage (I/II) group; (C) Ann arbor stage (III/IV) group; (D) CA (I/II) group; (E) CA (III/IV) group; (F) KPI (HIR/HR) group; (G) IPI (LR/LIR) group; (H) PINK (IR) group; (I) PINK (HR) group; (J) LMP1-negative group; (K) CD38 tumor cells-positive group; (L) CD163-positive group; (M) CD68-positive group; (N) PD1 tumor cells-negative group; (O) PD1 background cells-negative group; (P) PD1background cells-positive group; (Q) P53-positive group; (R) CD152-positive group; (S) CD30-negative group; (T) CD30-positive group; LR: low risk; LIR: low intermediate risk; HIR: high intermediate risk; HR: high risk.</p></figcaption></figure></section></section><section id="S0004"><h2 class="pmc_sec_title">Discussion</h2>
<p>In this study, we explored the clinicopathological characteristics and prognostic values of co-stimulatory molecules OX40 and ICOS in ENKTL, identifying a positive correlation between OX40 expression and overall survival. To the best of our knowledge, this is the first study to assess the associations of OX40 and ICOS with ENKTL.</p>
<p>The lymphoma microenvironment has emerged as an important factor, particularly in the era of immunotherapy and targeted treatments. Its influence extends beyond treatment efficacy to enabling the development of more precise, individualized treatments. In our study, OX40 was expressed in 78% of the cases, with 12 showing expression levels exceeding 30%. Moreover, our results indicated a positive association between OX40 expression and improved survival outcomes in patients with ENKTL. Ramser et al. [<a href="#CIT0025" class="usa-link" aria-describedby="CIT0025">25</a>] reported that a high density of OX40-positive immune cells in recurrent cancer biopsies was significantly associated with better survival rates. Additionally, a cross-sectional study involving 20 patients demonstrated a positive correlation between OX40 expression on CD4+/CD8+ T cells and progression-free survival [<a href="#CIT0026" class="usa-link" aria-describedby="CIT0026">26</a>]. Similarly, Lu et al. [<a href="#CIT0018" class="usa-link" aria-describedby="CIT0018">18</a>] observed that patients with DLBCL exhibiting high OX40 expression experienced significantly better clinical outcomes. Nevertheless, the prevalence and prognostic value of OX40 expression in ENKTL require further exploration.</p>
<p>There are several possible mechanisms that could explain the positive association between OX40 expression and improved survival. First, OX40 is primarily expressed on activated CD4+ and CD8+ T cells as well as Foxp3+ CD4+ regulatory T cells (Tregs) [<a href="#CIT0027" class="usa-link" aria-describedby="CIT0027">27</a>,<a href="#CIT0028" class="usa-link" aria-describedby="CIT0028">28</a>]. The ligand for OX40 is OX40L. By binding with OX40L, OX40 can initiate a series of signal transduction events in T cells, including the recruitment of TNF receptor-associated factors, and the activation of key kinases such as IkappaB Kinase α/β, and phosphoinositide 3-kinases [<a href="#CIT0029" class="usa-link" aria-describedby="CIT0029">29–31</a>]. These signaling pathways not only enhance the survival and proliferation capabilities of T cells but also improve their functional responsiveness to antigens presented within the tumor environment, leading to an intensified cytotoxic attack on tumor cells. Second, the interaction between OX40 and OX40L can also regulate the production of cytokines, including enhancing the production of IL-2 and IFN-γ, and reducing the production of IL-10 [<a href="#CIT0032" class="usa-link" aria-describedby="CIT0032">32</a>,<a href="#CIT0033" class="usa-link" aria-describedby="CIT0033">33</a>]. This cytokine modulation is crucial for orchestrating an effective immune response, as IL-2 and IFN-γ are pivotal in enhancing T cell effector functions, while reducing IL-10 helps diminish the immunosuppressive environment typically fostered by tumors. Furthermore, prior research indicates that OX40 signaling can promote the generation of long-lived memory T cells, thereby enhancing immune memory [<a href="#CIT0034" class="usa-link" aria-describedby="CIT0034">34</a>,<a href="#CIT0035" class="usa-link" aria-describedby="CIT0035">35</a>]. In addition, combined treatments involving OX40 agonists and other immunotherapies may potentiate anti-tumor responses and improve survival rates.</p>
<p>In this current study, we observed that among the 48 patients with positive ICOS expression, 65% (<em>n</em> = 31) cases exhibited a minimal expression level of 1%. Moreover, there was no statistically significant difference in survival rates between patients who were ICOS-negative and those who were ICOS-positive. This minimal expression might not be biologically significant enough to impact the OS of ENKTL. Besides, the sample size may be too small to detect survival differences. Further investigation, which includes a larger cohort of patients, or different thresholds for ICOS positivity to clarify the potential role of ICOS in ENKTL. Additionally, we observed a statistically significant difference in the proportion of CD152-positive background cells between the ICOS status groups. CD152 is an immune checkpoint molecule predominantly expressed on regulatory T cells and activated T cells, playing a key role in maintaining immune homeostasis. This finding may reflect subtle immunological differences in the tumor microenvironment associated with ICOS status, although its clinical significance in ENKTL requires further elucidation.</p>
<p>When examining the combined positive expression of OX40 and ICOS, a marked improvement in survival rates was observed in the group of patients dual expressing, compared to those without such expression. This correlation could be attributed to several potential reasons. ICOS and OX40 are both co-stimulatory molecules on the surface of T cells, and their expression can lead to increased T cell activation and proliferation [<a href="#CIT0036" class="usa-link" aria-describedby="CIT0036">36</a>,<a href="#CIT0037" class="usa-link" aria-describedby="CIT0037">37</a>]. Their expression is associated with the formation of long-term immune memory [<a href="#CIT0038" class="usa-link" aria-describedby="CIT0038">38</a>,<a href="#CIT0039" class="usa-link" aria-describedby="CIT0039">39</a>], which could help the immune system in effectively responding to tumor growth. Furthermore, these molecules may modify the tumor microenvironment, making it more conducive to immune cell infiltration and function [<a href="#CIT0040" class="usa-link" aria-describedby="CIT0040">40–42</a>].</p>
<p>The strengths of our study include its long-term follow-up and the first-time investigation of the clinicopathological differences of ICOS and OX40 in ENKTL. Additionally, we conducted a detailed subgroup analysis of ICOS and OX40 status across various clinical pathological indicators. However, limitations of the current study are worth noting. First, we were unable to identify the cut-off points for OX40 and ICOS expression, which may affect the generalizability of the prognostic thresholds. Second, although our findings indicated that positive OX40 expression was a favorable prognostic factor in ENKTL, the limited sample size necessitates further large-scale, multicenter studies to explore the prognostic values of ICOS and OX40 in ENKTL more comprehensively. Lastly, the variation in treatment regimens across the study period was not stratified in this analysis, which could potentially influence the prognostic implications of OX40 and ICOS expression. Future research should incorporate these variables to more accurately elucidate how treatment strategies interact with biomarker performance and influence patient outcomes.</p>
<p>In conclusion, positive OX40 expression could serve as an independent prognostic marker for improved survival of ENKTL. While further studies are needed to clarify the impact of ICOS in ENKTL.</p></section><section id="sec19"><h2 class="pmc_sec_title">Supplementary Material</h2>
<section class="sm xbox font-sm" id="SM6772"><div class="caption p"><span>Supplementary_Table_1.docx</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12377112/bin/IANN_A_2550583_SM6772.docx" data-ga-action="click_feat_suppl" class="usa-link">IANN_A_2550583_SM6772.docx</a><sup> (21.4KB, docx) </sup>
</div></div></section></section><section id="funding-statement1" lang="en"><h2 class="pmc_sec_title">Funding Statement</h2>
<p>This study was funded by National Natural Science Foundation of China (82470192), the Natural Science Foundation of Jiangsu Province (BK20171181), Jiangsu Key Research and Development Project of Social Development (BE2019638), Young Medical Talents of Jiangsu Science and Education Health Project (QNRC2016791), and Jiangsu Province High-Level Hospital Construction Project (GSPJS202417, GSPJS202420, GSPJS202414).</p></section><section id="S0005"><h2 class="pmc_sec_title">Author contributions</h2>
<p>ZS, HL, and WS contributed to the concept and design; ZS and HZ contributed to the methods and analysis. HZ and YL contributed to the drafting. QZ, YW, SZ, and XX contributed to data collection. All authors approve the final version.</p></section><section id="S0006"><h2 class="pmc_sec_title">Disclosure statement</h2>
<p>No potential conflict of interest was reported by the author(s).</p></section><section id="S0007"><h2 class="pmc_sec_title">Ethical approval</h2>
<p>The study was approved by the Ethics Committee of the Affiliated Hospital of Xuzhou Medical University (No. XYFY2022-KL363-01). All participants provided written informed consent.</p></section><section id="S0008"><h2 class="pmc_sec_title">Data availability statement</h2>
<p>The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CIT0001">
<span class="label">1.</span><cite>Xiong J, Zhao W.. 
What we should know about natural killer/T-cell lymphomas. Hematol Oncol. 2019;37(S1):75–81. doi: 10.1002/hon.2588.</cite> [<a href="https://doi.org/10.1002/hon.2588" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31187536/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hematol%20Oncol&amp;title=What%20we%20should%20know%20about%20natural%20killer/T-cell%20lymphomas&amp;volume=37&amp;issue=S1&amp;publication_year=2019&amp;pages=75-81&amp;pmid=31187536&amp;doi=10.1002/hon.2588&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0002">
<span class="label">2.</span><cite>He H-X, Gao Y, Fu J-C, et al. 
VISTA and PD-L1 synergistically predict poor prognosis in patients with extranodal natural killer/T-cell lymphoma. Oncoimmunology. 2021;10(1):1907059. doi: 10.1080/2162402X.2021.1907059.
</cite> [<a href="https://doi.org/10.1080/2162402X.2021.1907059" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8032243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33889438/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncoimmunology&amp;title=VISTA%20and%20PD-L1%20synergistically%20predict%20poor%20prognosis%20in%20patients%20with%20extranodal%20natural%20killer/T-cell%20lymphoma&amp;volume=10&amp;issue=1&amp;publication_year=2021&amp;pages=1907059&amp;pmid=33889438&amp;doi=10.1080/2162402X.2021.1907059&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0003">
<span class="label">3.</span><cite>van Doesum JA, Niezink AG, Huls GA, et al. 
Extranodal natural killer/T-cell lymphoma, nasal type: diagnosis and treatment. Hemasphere. 2021;5(2):e523. doi: 10.1097/HS9.0000000000000523.
</cite> [<a href="https://doi.org/10.1097/HS9.0000000000000523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7806244/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33458595/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hemasphere&amp;title=Extranodal%20natural%20killer/T-cell%20lymphoma,%20nasal%20type:%20diagnosis%20and%20treatment&amp;volume=5&amp;issue=2&amp;publication_year=2021&amp;pages=e523&amp;pmid=33458595&amp;doi=10.1097/HS9.0000000000000523&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0004">
<span class="label">4.</span><cite>Fox CP, Civallero M, Ko Y-H, et al. 
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. Lancet Haematol. 2020;7(4):e284–e94. doi: 10.1016/S2352-3026(19)30283-2.
</cite> [<a href="https://doi.org/10.1016/S2352-3026(19)30283-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32105608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Haematol&amp;title=Survival%20outcomes%20of%20patients%20with%20extranodal%20natural-killer%20T-cell%20lymphoma:%20a%20prospective%20cohort%20study%20from%20the%20international%20T-cell%20Project&amp;volume=7&amp;issue=4&amp;publication_year=2020&amp;pages=e284-e94&amp;pmid=32105608&amp;doi=10.1016/S2352-3026(19)30283-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0005">
<span class="label">5.</span><cite>Bu S, Yuan F, Wei X, et al. 
L-asparaginase-based regimen as a first-line treatment for newly diagnosed nasal type extranodal natural killer cell/T-cell lymphoma. Exp Ther Med. 2016;11(6):2437–2445. doi: 10.3892/etm.2016.3249.
</cite> [<a href="https://doi.org/10.3892/etm.2016.3249" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4888054/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27313673/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp%20Ther%20Med&amp;title=L-asparaginase-based%20regimen%20as%20a%20first-line%20treatment%20for%20newly%20diagnosed%20nasal%20type%20extranodal%20natural%20killer%20cell/T-cell%20lymphoma&amp;volume=11&amp;issue=6&amp;publication_year=2016&amp;pages=2437-2445&amp;pmid=27313673&amp;doi=10.3892/etm.2016.3249&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0006">
<span class="label">6.</span><cite>Zhang Y, Liu Y, Xia Z, et al. 
Phase II study of sequential chemoradiotherapy with L-asparaginase, dexamethasone, ifosfamide, cisplatin, and etoposide (DICE-L) in the early stage of extranodal natural killer (NK)/T-cell lymphoma. Ann Transl Med. 2021;9(14):1178–1178. doi: 10.21037/atm-21-3525.
</cite> [<a href="https://doi.org/10.21037/atm-21-3525" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8350702/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34430619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Transl%20Med&amp;title=Phase%20II%20study%20of%20sequential%20chemoradiotherapy%20with%20L-asparaginase,%20dexamethasone,%20ifosfamide,%20cisplatin,%20and%20etoposide%20(DICE-L)%20in%20the%20early%20stage%20of%20extranodal%20natural%20killer%20(NK)/T-cell%20lymphoma&amp;volume=9&amp;issue=14&amp;publication_year=2021&amp;pages=1178-1178&amp;pmid=34430619&amp;doi=10.21037/atm-21-3525&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0007">
<span class="label">7.</span><cite>Wu W, Ren K, Chen X, et al. 
Comparison of the clinical efficacies of two L-asparaginase-based chemotherapy regimens for newly diagnosed nasal-type extranodal NK/T-cell lymphoma. Cancer Med. 2023;12(8):9458–9470. doi: 10.1002/cam4.5708.
</cite> [<a href="https://doi.org/10.1002/cam4.5708" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10166983/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37000008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Med&amp;title=Comparison%20of%20the%20clinical%20efficacies%20of%20two%20L-asparaginase-based%20chemotherapy%20regimens%20for%20newly%20diagnosed%20nasal-type%20extranodal%20NK/T-cell%20lymphoma&amp;volume=12&amp;issue=8&amp;publication_year=2023&amp;pages=9458-9470&amp;pmid=37000008&amp;doi=10.1002/cam4.5708&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0008">
<span class="label">8.</span><cite>Armengol M, Santos JC, Fernández-Serrano M, et al. 
Immune-checkpoint inhibitors in B-cell lymphoma. Cancers (Basel). 2021;13(2):214. doi: 10.3390/cancers13020214.
</cite> [<a href="https://doi.org/10.3390/cancers13020214" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7827333/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33430146/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers%20(Basel)&amp;title=Immune-checkpoint%20inhibitors%20in%20B-cell%20lymphoma&amp;volume=13&amp;issue=2&amp;publication_year=2021&amp;pages=214&amp;pmid=33430146&amp;doi=10.3390/cancers13020214&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0009">
<span class="label">9.</span><cite>Ansell SM, Lesokhin AM, Borrello I, et al. 
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. N Engl J Med. 2015;372(4):311–319. doi: 10.1056/NEJMoa1411087.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1411087" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4348009/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25482239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=PD-1%20blockade%20with%20nivolumab%20in%20relapsed%20or%20refractory%20Hodgkin%E2%80%99s%20lymphoma&amp;volume=372&amp;issue=4&amp;publication_year=2015&amp;pages=311-319&amp;pmid=25482239&amp;doi=10.1056/NEJMoa1411087&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0010">
<span class="label">10.</span><cite>Armand P.
Immune checkpoint blockade in hematologic malignancies. Blood, The Journal of the American Society of Hematology. 2015;125(22):3393–3400. doi: 10.1182/blood-2015-02-567453.</cite> [<a href="https://doi.org/10.1182/blood-2015-02-567453" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25833961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood,%20The%20Journal%20of%20the%20American%20Society%20of%20Hematology&amp;title=Immune%20checkpoint%20blockade%20in%20hematologic%20malignancies&amp;volume=125&amp;issue=22&amp;publication_year=2015&amp;pages=3393-3400&amp;pmid=25833961&amp;doi=10.1182/blood-2015-02-567453&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0011">
<span class="label">11.</span><cite>Lesokhin AM, Ansell SM, Armand P, et al. 
Nivolumab in patients with relapsed or refractory hematologic malignancy: preliminary results of a phase Ib study. J Clin Oncol. 2016;34(23):2698–2704. doi: 10.1200/JCO.2015.65.9789.
</cite> [<a href="https://doi.org/10.1200/JCO.2015.65.9789" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5019749/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27269947/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Oncol&amp;title=Nivolumab%20in%20patients%20with%20relapsed%20or%20refractory%20hematologic%20malignancy:%20preliminary%20results%20of%20a%20phase%20Ib%20study&amp;volume=34&amp;issue=23&amp;publication_year=2016&amp;pages=2698-2704&amp;pmid=27269947&amp;doi=10.1200/JCO.2015.65.9789&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0012">
<span class="label">12.</span><cite>Topalian SL, Hodi FS, Brahmer JR, et al. 
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer. N Engl J Med. 2012;366(26):2443–2454. doi: 10.1056/NEJMoa1200690.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1200690" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3544539/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22658127/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=Safety,%20activity,%20and%20immune%20correlates%20of%20anti%E2%80%93PD-1%20antibody%20in%20cancer&amp;volume=366&amp;issue=26&amp;publication_year=2012&amp;pages=2443-2454&amp;pmid=22658127&amp;doi=10.1056/NEJMoa1200690&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0013">
<span class="label">13.</span><cite>Conniot J, Scomparin A, Peres C, et al. 
Immunization with mannosylated nanovaccines and inhibition of the immune-suppressing microenvironment sensitizes melanoma to immune checkpoint modulators. Nat Nanotechnol. 2019;14(9):891–901. doi: 10.1038/s41565-019-0512-0.
</cite> [<a href="https://doi.org/10.1038/s41565-019-0512-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31384037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Nanotechnol&amp;title=Immunization%20with%20mannosylated%20nanovaccines%20and%20inhibition%20of%20the%20immune-suppressing%20microenvironment%20sensitizes%20melanoma%20to%20immune%20checkpoint%20modulators&amp;volume=14&amp;issue=9&amp;publication_year=2019&amp;pages=891-901&amp;pmid=31384037&amp;doi=10.1038/s41565-019-0512-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0014">
<span class="label">14.</span><cite>Amatore F, Gorvel L, Olive D.. 
Inducible Co-Stimulator (ICOS) as a potential therapeutic target for anti-cancer therapy. Expert Opin Ther Targets. 2018;22(4):343–351. doi: 10.1080/14728222.2018.1444753.
</cite> [<a href="https://doi.org/10.1080/14728222.2018.1444753" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29468927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Ther%20Targets&amp;title=Inducible%20Co-Stimulator%20(ICOS)%20as%20a%20potential%20therapeutic%20target%20for%20anti-cancer%20therapy&amp;volume=22&amp;issue=4&amp;publication_year=2018&amp;pages=343-351&amp;pmid=29468927&amp;doi=10.1080/14728222.2018.1444753&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0015">
<span class="label">15.</span><cite>Moreno-Cortes E, Franco-Fuquen P, Garcia-Robledo JE, et al. 
ICOS and OX40 tandem co-stimulation enhances CAR T-cell cytotoxicity and promotes T-cell persistence phenotype. Front Oncol. 2023;13:1200914. doi: 10.3389/fonc.2023.1200914.
</cite> [<a href="https://doi.org/10.3389/fonc.2023.1200914" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10502212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37719008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Front%20Oncol&amp;title=ICOS%20and%20OX40%20tandem%20co-stimulation%20enhances%20CAR%20T-cell%20cytotoxicity%20and%20promotes%20T-cell%20persistence%20phenotype&amp;volume=13&amp;publication_year=2023&amp;pages=1200914&amp;pmid=37719008&amp;doi=10.3389/fonc.2023.1200914&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0016">
<span class="label">16.</span><cite>Guedan S, Posey AD, Shaw C, et al. 
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation. JCI Insight. 2018;3(1):2018. doi: 10.1172/jci.insight.96976.</cite> [<a href="https://doi.org/10.1172/jci.insight.96976" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5821198/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29321369/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=JCI%20Insight&amp;title=Enhancing%20CAR%20T%20cell%20persistence%20through%20ICOS%20and%204-1BB%20costimulation&amp;volume=3&amp;issue=1&amp;publication_year=2018&amp;pages=2018&amp;pmid=29321369&amp;doi=10.1172/jci.insight.96976&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0017">
<span class="label">17.</span><cite>Tsuchiya T, Ohshima K, Karube K, et al. 
Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL. Blood. 2004;103(1):236–241. doi: 10.1182/blood-2002-05-1352.
</cite> [<a href="https://doi.org/10.1182/blood-2002-05-1352" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12958063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=Th1,%20Th2,%20and%20activated%20T-cell%20marker%20and%20clinical%20prognosis%20in%20peripheral%20T-cell%20lymphoma,%20unspecified:%20comparison%20with%20AILD,%20ALCL,%20lymphoblastic%20lymphoma,%20and%20ATLL&amp;volume=103&amp;issue=1&amp;publication_year=2004&amp;pages=236-241&amp;pmid=12958063&amp;doi=10.1182/blood-2002-05-1352&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0018">
<span class="label">18.</span><cite>Lu Y, Li Y, Yu J, et al. 
OX40 shapes an inflamed tumor immune microenvironment and predicts response to immunochemotherapy in diffuse large B-cell lymphoma. Clin Immunol. 2023;251:109637. doi: 10.1016/j.clim.2023.109637.
</cite> [<a href="https://doi.org/10.1016/j.clim.2023.109637" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37150239/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Immunol&amp;title=OX40%20shapes%20an%20inflamed%20tumor%20immune%20microenvironment%20and%20predicts%20response%20to%20immunochemotherapy%20in%20diffuse%20large%20B-cell%20lymphoma&amp;volume=251&amp;publication_year=2023&amp;pages=109637&amp;pmid=37150239&amp;doi=10.1016/j.clim.2023.109637&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0019">
<span class="label">19.</span><cite>Kim SJ, Yoon DH, Jaccard A, et al. 
A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis. Lancet Oncol. 2016;17(3):389–400. doi: 10.1016/S1470-2045(15)00533-1.
</cite> [<a href="https://doi.org/10.1016/S1470-2045(15)00533-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26873565/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Lancet%20Oncol&amp;title=A%20prognostic%20index%20for%20natural%20killer%20cell%20lymphoma%20after%20non-anthracycline-based%20treatment:%20a%20multicentre,%20retrospective%20analysis&amp;volume=17&amp;issue=3&amp;publication_year=2016&amp;pages=389-400&amp;pmid=26873565&amp;doi=10.1016/S1470-2045(15)00533-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0020">
<span class="label">20.</span><cite>A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med. 1993;329(14):987–994. doi: 10.1056/nejm199309303291402.
</cite> [<a href="https://doi.org/10.1056/nejm199309303291402" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8141877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=N%20Engl%20J%20Med&amp;title=A%20predictive%20model%20for%20aggressive%20non-Hodgkin%E2%80%99s%20lymphoma&amp;volume=329&amp;issue=14&amp;publication_year=1993&amp;pages=987-994&amp;pmid=8141877&amp;doi=10.1056/nejm199309303291402&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0021">
<span class="label">21.</span><cite>Shen Z, Zhang S, Chen X, et al. 
Prognostic value of prognostic nutritional index on extranodal natural killer/T‐cell lymphoma patients: a multicenter propensity score matched analysis of 1022 cases in Huaihai Lymphoma Working Group. Hematol Oncol. 2023;41(3):380–388. doi: 10.1002/hon.3124.
</cite> [<a href="https://doi.org/10.1002/hon.3124" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36680513/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hematol%20Oncol&amp;title=Prognostic%20value%20of%20prognostic%20nutritional%20index%20on%20extranodal%20natural%20killer/T%E2%80%90cell%20lymphoma%20patients:%20a%20multicenter%20propensity%20score%20matched%20analysis%20of%201022%20cases%20in%20Huaihai%20Lymphoma%20Working%20Group&amp;volume=41&amp;issue=3&amp;publication_year=2023&amp;pages=380-388&amp;pmid=36680513&amp;doi=10.1002/hon.3124&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0022">
<span class="label">22.</span><cite>Ferraris A, Giuntini P, Gaetani G.. 
Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas. 1979.</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/476306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ferraris%20A,%20Giuntini%20P,%20Gaetani%20G..%20Serum%20lactic%20dehydrogenase%20as%20a%20prognostic%20tool%20for%20non-Hodgkin%20lymphomas.%201979." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0023">
<span class="label">23.</span><cite>Chen S-Y, Yang Y, Qi S-N, et al. 
Validation of nomogram-revised risk index and comparison with other models for extranodal nasal-type NK/T-cell lymphoma in the modern chemotherapy era: indication for prognostication and clinical decision-making. Leukemia. 2021;35(1):130–142. doi: 10.1038/s41375-020-0791-3.
</cite> [<a href="https://doi.org/10.1038/s41375-020-0791-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7787971/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32152465/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=Validation%20of%20nomogram-revised%20risk%20index%20and%20comparison%20with%20other%20models%20for%20extranodal%20nasal-type%20NK/T-cell%20lymphoma%20in%20the%20modern%20chemotherapy%20era:%20indication%20for%20prognostication%20and%20clinical%20decision-making&amp;volume=35&amp;issue=1&amp;publication_year=2021&amp;pages=130-142&amp;pmid=32152465&amp;doi=10.1038/s41375-020-0791-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0024">
<span class="label">24.</span><cite>Hong H, Li Y, Lim ST, et al. 
A proposal for a new staging system for extranodal natural killer T-cell lymphoma: a multicenter study from China and Asia Lymphoma Study Group. Leukemia. 2020;34(8):2243–2248. doi: 10.1038/s41375-020-0740-1.
</cite> [<a href="https://doi.org/10.1038/s41375-020-0740-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7387308/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32066865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Leukemia&amp;title=A%20proposal%20for%20a%20new%20staging%20system%20for%20extranodal%20natural%20killer%20T-cell%20lymphoma:%20a%20multicenter%20study%20from%20China%20and%20Asia%20Lymphoma%20Study%20Group&amp;volume=34&amp;issue=8&amp;publication_year=2020&amp;pages=2243-2248&amp;pmid=32066865&amp;doi=10.1038/s41375-020-0740-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0025">
<span class="label">25.</span><cite>Ramser M, Eichelberger S, Däster S, et al. 
High OX40 expression in recurrent ovarian carcinoma is indicative for response to repeated chemotherapy. BMC Cancer. 2018;18(1):425. doi: 10.1186/s12885-018-4339-0.
</cite> [<a href="https://doi.org/10.1186/s12885-018-4339-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5903007/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29661166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=High%20OX40%20expression%20in%20recurrent%20ovarian%20carcinoma%20is%20indicative%20for%20response%20to%20repeated%20chemotherapy&amp;volume=18&amp;issue=1&amp;publication_year=2018&amp;pages=425&amp;pmid=29661166&amp;doi=10.1186/s12885-018-4339-0&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0026">
<span class="label">26.</span><cite>Ohmura H, Yamaguchi K, Hanamura F, et al. Activation of central/effector memory T cells in advanced gastric cancer patients treated with antiprogrammed death-1 antibody. J Clin Oncol. 2019;37(4_suppl):54. doi: 10.1200/JCO.2019.37.4_suppl.54</cite> [<a href="https://doi.org/10.1200/JCO.2019.37.4_suppl.54" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?Ohmura%20H,%20Yamaguchi%20K,%20Hanamura%20F,%20et%20al.%20Activation%20of%20central/effector%20memory%20T%20cells%20in%20advanced%20gastric%20cancer%20patients%20treated%20with%20antiprogrammed%20death-1%20antibody.%20J%20Clin%20Oncol.%202019;37(4_suppl):54.%20doi:%2010.1200/JCO.2019.37.4_suppl.54" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0027">
<span class="label">27.</span><cite>Paterson DJ, Jefferies WA, Green JR, et al. 
Antigens of activated rat T lymphocytes including a molecule of 50,000 Mr detected only on CD4 positive T blasts. Mol Immunol. 1987;24(12):1281–1290. doi: 10.1016/0161-5890(87)90122-2.
</cite> [<a href="https://doi.org/10.1016/0161-5890(87)90122-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2828930/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Immunol&amp;title=Antigens%20of%20activated%20rat%20T%20lymphocytes%20including%20a%20molecule%20of%2050,000%20Mr%20detected%20only%20on%20CD4%20positive%20T%20blasts&amp;volume=24&amp;issue=12&amp;publication_year=1987&amp;pages=1281-1290&amp;pmid=2828930&amp;doi=10.1016/0161-5890(87)90122-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0028">
<span class="label">28.</span><cite>Mallett S, Fossum S, Barclay AN.. 
Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes--a molecule related to nerve growth factor receptor. Embo J. 1990;9(4):1063–1068. doi: 10.1002/j.1460-2075.1990.tb08211.x.
</cite> [<a href="https://doi.org/10.1002/j.1460-2075.1990.tb08211.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC551780/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2157591/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Embo%20J&amp;title=Characterization%20of%20the%20MRC%20OX40%20antigen%20of%20activated%20CD4%20positive%20T%20lymphocytes--a%20molecule%20related%20to%20nerve%20growth%20factor%20receptor&amp;volume=9&amp;issue=4&amp;publication_year=1990&amp;pages=1063-1068&amp;pmid=2157591&amp;doi=10.1002/j.1460-2075.1990.tb08211.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0029">
<span class="label">29.</span><cite>Takaori-Kondo A, Hori T, Fukunaga K, et al. 
Both amino-and carboxyl-terminal domains of TRAF3 negatively regulate NF-κB activation induced by OX40 signaling. Biochem Biophys Res Commun. 2000;272(3):856–863. doi: 10.1006/bbrc.2000.2860.
</cite> [<a href="https://doi.org/10.1006/bbrc.2000.2860" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10860842/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&amp;title=Both%20amino-and%20carboxyl-terminal%20domains%20of%20TRAF3%20negatively%20regulate%20NF-%CE%BAB%20activation%20induced%20by%20OX40%20signaling&amp;volume=272&amp;issue=3&amp;publication_year=2000&amp;pages=856-863&amp;pmid=10860842&amp;doi=10.1006/bbrc.2000.2860&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0030">
<span class="label">30.</span><cite>So T, Choi H, Croft M.. 
OX40 complexes with phosphoinositide 3-kinase and protein kinase B (PKB) to augment TCR-dependent PKB signaling. J Immunol. 2011;186(6):3547–3555. doi: 10.4049/jimmunol.1003156.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1003156" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3079230/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21289304/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunol&amp;title=OX40%20complexes%20with%20phosphoinositide%203-kinase%20and%20protein%20kinase%20B%20(PKB)%20to%20augment%20TCR-dependent%20PKB%20signaling&amp;volume=186&amp;issue=6&amp;publication_year=2011&amp;pages=3547-3555&amp;pmid=21289304&amp;doi=10.4049/jimmunol.1003156&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0031">
<span class="label">31.</span><cite>Arch RH, Thompson CB.. 
4-1BB and Ox40 are members of a tumor necrosis factor (TNF)-nerve growth factor receptor subfamily that bind TNF receptor-associated factors and activate nuclear factor κB. Mol Cell Biol. 1998;18(1):558–565. doi: 10.1128/MCB.18.1.558.
</cite> [<a href="https://doi.org/10.1128/MCB.18.1.558" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC121523/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9418902/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Biol&amp;title=4-1BB%20and%20Ox40%20are%20members%20of%20a%20tumor%20necrosis%20factor%20(TNF)-nerve%20growth%20factor%20receptor%20subfamily%20that%20bind%20TNF%20receptor-associated%20factors%20and%20activate%20nuclear%20factor%20%CE%BAB&amp;volume=18&amp;issue=1&amp;publication_year=1998&amp;pages=558-565&amp;pmid=9418902&amp;doi=10.1128/MCB.18.1.558&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0032">
<span class="label">32.</span><cite>Xiao X, Gong W, Demirci G, et al. 
New insights on OX40 in the control of T cell immunity and immune tolerance in vivo. J Immunol. 2012;188(2):892–901. doi: 10.4049/jimmunol.1101373.
</cite> [<a href="https://doi.org/10.4049/jimmunol.1101373" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3262989/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22147766/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunol&amp;title=New%20insights%20on%20OX40%20in%20the%20control%20of%20T%20cell%20immunity%20and%20immune%20tolerance%20in%20vivo&amp;volume=188&amp;issue=2&amp;publication_year=2012&amp;pages=892-901&amp;pmid=22147766&amp;doi=10.4049/jimmunol.1101373&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0033">
<span class="label">33.</span><cite>Wang Y, Li M, Song M, et al. 
Expression of OX40 ligand in microglia activated by IFN-γ sustains a protective CD4+ T-cell response in vitro. Cell Immunol. 2008;251(2):86–92. doi: 10.1016/j.cellimm.2008.04.002.
</cite> [<a href="https://doi.org/10.1016/j.cellimm.2008.04.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18485335/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell%20Immunol&amp;title=Expression%20of%20OX40%20ligand%20in%20microglia%20activated%20by%20IFN-%CE%B3%20sustains%20a%20protective%20CD4+%20T-cell%20response%20in%20vitro&amp;volume=251&amp;issue=2&amp;publication_year=2008&amp;pages=86-92&amp;pmid=18485335&amp;doi=10.1016/j.cellimm.2008.04.002&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0034">
<span class="label">34.</span><cite>Mousavi SF, Soroosh P, Takahashi T, et al. 
OX40 costimulatory signals potentiate the memory commitment of effector CD8+ T cells. J Immunol. 2008;181(9):5990–6001. doi: 10.4049/jimmunol.181.9.5990.
</cite> [<a href="https://doi.org/10.4049/jimmunol.181.9.5990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2784683/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18941188/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Immunol&amp;title=OX40%20costimulatory%20signals%20potentiate%20the%20memory%20commitment%20of%20effector%20CD8+%20T%20cells&amp;volume=181&amp;issue=9&amp;publication_year=2008&amp;pages=5990-6001&amp;pmid=18941188&amp;doi=10.4049/jimmunol.181.9.5990&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0035">
<span class="label">35.</span><cite>Croft M, So T, Duan W, et al. 
The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev. 2009;229(1):173–191. doi: 10.1111/j.1600-065X.2009.00766.x.
</cite> [<a href="https://doi.org/10.1111/j.1600-065X.2009.00766.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2729757/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19426222/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunol%20Rev&amp;title=The%20significance%20of%20OX40%20and%20OX40L%20to%20T-cell%20biology%20and%20immune%20disease&amp;volume=229&amp;issue=1&amp;publication_year=2009&amp;pages=173-191&amp;pmid=19426222&amp;doi=10.1111/j.1600-065X.2009.00766.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0036">
<span class="label">36.</span><cite>Peng C, Huggins MA, Wanhainen KM, et al. 
Engagement of the costimulatory molecule ICOS in tissues promotes establishment of CD8(+) tissue-resident memory T cells. Immunity. 2022;55(1):98–114.e5. doi: 10.1016/j.immuni.2021.11.017.
</cite> [<a href="https://doi.org/10.1016/j.immuni.2021.11.017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8755622/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34932944/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Immunity&amp;title=Engagement%20of%20the%20costimulatory%20molecule%20ICOS%20in%20tissues%20promotes%20establishment%20of%20CD8(+)%20tissue-resident%20memory%20T%20cells&amp;volume=55&amp;issue=1&amp;publication_year=2022&amp;pages=98-114.e5&amp;pmid=34932944&amp;doi=10.1016/j.immuni.2021.11.017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0037">
<span class="label">37.</span><cite>Fu Y, Lin Q, Zhang Z, et al. 
Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity. Acta Pharm Sin B. 2020;10(3):414–433. doi: 10.1016/j.apsb.2019.08.010.
</cite> [<a href="https://doi.org/10.1016/j.apsb.2019.08.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7049610/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32140389/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Acta%20Pharm%20Sin%20B&amp;title=Therapeutic%20strategies%20for%20the%20costimulatory%20molecule%20OX40%20in%20T-cell-mediated%20immunity&amp;volume=10&amp;issue=3&amp;publication_year=2020&amp;pages=414-433&amp;pmid=32140389&amp;doi=10.1016/j.apsb.2019.08.010&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0038">
<span class="label">38.</span><cite>Marin-Acevedo JA, Dholaria B, Soyano AE, et al. 
Next generation of immune checkpoint therapy in cancer: new developments and challenges. J Hematol Oncol. 2018;11(1):39. doi: 10.1186/s13045-018-0582-8.
</cite> [<a href="https://doi.org/10.1186/s13045-018-0582-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5856308/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29544515/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Hematol%20Oncol&amp;title=Next%20generation%20of%20immune%20checkpoint%20therapy%20in%20cancer:%20new%20developments%20and%20challenges&amp;volume=11&amp;issue=1&amp;publication_year=2018&amp;pages=39&amp;pmid=29544515&amp;doi=10.1186/s13045-018-0582-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0039">
<span class="label">39.</span><cite>Lu X.
OX40 and OX40L Interaction in Cancer. Curr Med Chem. 2021;28(28):5659–5673. doi: 10.2174/0929867328666201229123151.
</cite> [<a href="https://doi.org/10.2174/0929867328666201229123151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33372866/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Med%20Chem&amp;title=OX40%20and%20OX40L%20Interaction%20in%20Cancer&amp;volume=28&amp;issue=28&amp;publication_year=2021&amp;pages=5659-5673&amp;pmid=33372866&amp;doi=10.2174/0929867328666201229123151&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0040">
<span class="label">40.</span><cite>Amatore F, Gorvel L, Olive D.. 
Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy. Expert Opin Biol Ther. 2020;20(2):141–150. doi: 10.1080/14712598.2020.1693540.
</cite> [<a href="https://doi.org/10.1080/14712598.2020.1693540" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31738626/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Expert%20Opin%20Biol%20Ther&amp;title=Role%20of%20Inducible%20Co-Stimulator%20(ICOS)%20in%20cancer%20immunotherapy&amp;volume=20&amp;issue=2&amp;publication_year=2020&amp;pages=141-150&amp;pmid=31738626&amp;doi=10.1080/14712598.2020.1693540&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0041">
<span class="label">41.</span><cite>Dong C, Nurieva RI.. 
Regulation of immune and autoimmune responses by ICOS. J Autoimmun. 2003;21(3):255–260. doi: 10.1016/s0896-8411(03)00119-7.
</cite> [<a href="https://doi.org/10.1016/s0896-8411(03)00119-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14599850/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Autoimmun&amp;title=Regulation%20of%20immune%20and%20autoimmune%20responses%20by%20ICOS&amp;volume=21&amp;issue=3&amp;publication_year=2003&amp;pages=255-260&amp;pmid=14599850&amp;doi=10.1016/s0896-8411(03)00119-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CIT0042">
<span class="label">42.</span><cite>Webb GJ, Hirschfield GM, Lane PJ.. 
OX40, OX40L and Autoimmunity: a Comprehensive Review. Clin Rev Allergy Immunol. 2016;50(3):312–332. doi: 10.1007/s12016-015-8498-3.
</cite> [<a href="https://doi.org/10.1007/s12016-015-8498-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26215166/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Rev%20Allergy%20Immunol&amp;title=OX40,%20OX40L%20and%20Autoimmunity:%20a%20Comprehensive%20Review&amp;volume=50&amp;issue=3&amp;publication_year=2016&amp;pages=312-332&amp;pmid=26215166&amp;doi=10.1007/s12016-015-8498-3&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="caption p"><span>Supplementary_Table_1.docx</span></div>
<div class="media p"><div class="caption">
<a href="/articles/instance/12377112/bin/IANN_A_2550583_SM6772.docx" data-ga-action="click_feat_suppl" class="usa-link">IANN_A_2550583_SM6772.docx</a><sup> (21.4KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets generated and/or analyzed during the current study are available from the corresponding author on reasonable request.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Annals of Medicine are provided here courtesy of <strong>Taylor & Francis</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1080/07853890.2025.2550583"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/IANN_57_2550583.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (7.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12377112/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12377112/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12377112%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12377112/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12377112/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12377112/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40847620/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12377112/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40847620/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12377112/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12377112/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="3o2KhFIHBIkxhU4ThMpEZqLMN2AosO4jBgs9z0TU0vHyfdaj02LnOHdTMK5NPr3c">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
